MARK2 antibody
Principal name
MARK2 antibody
Alternative names for MARK2 antibody
Serine/threonine-protein kinase, 2, ELKL motif kinase, EMK1, PAR1 homolog, MARK2, EMK1, MAP/microtubule affinity-regulating kinase
Ncbi ID
9606, NP_001034557, NP_001034558.2, NP_001034558.1, NP_059672.2, NM_004954, NP_004945, NP_059672, NM_001080388, NM_001080389, NM_001080390, NM_021699, NM_017490, NM_001163297, NM_001163296, NM_001039469
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of MARK2 antibody
MARK2 refers to MAP/microtubule affinity-regulating kinase 2 isoform a [Homo sapiens]. EMK (ELKL Motif Kinase) is a small family of ser/thr protein kinases involved in the control of cell polarity, microtubule
stability and cancer. Several cDNA clones have been isolated that encoded two isoforms of the human ser/thr protein kinase EMK1 called MARK2. These isoforms were characterized by the presence of a 162-bp alternative exon that gave rise to two forms, one containing the exon and the other one lacking it. Both forms were found to be coexpressed in a number of selected cell lines and tissue samples. Human MARK2 was shown to be encoded by a single mRNA ubiquitously expressed. This transcription variant includes the alternative exon in the coding region and therefore codes for a longer protein. Multiple splice variants exist for this protein.
Role in epithelial morphogenesis. Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells.










Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP09297PU-N | MARK2 pThr595 antibody |
||||||
![]() |
Rabbit | IgG | Aff - Purified | Bov, Can, Hu, Ms, Rt | E, WB |
0.1 mg /
€515.00
|
|
| OriGene Technologies GmbH | |||||||
| AP14909PU-N | MARK2 (C-term) antibody |
||||||
![]() |
Rabbit | Ig | Purified | Hu, Ms | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP310279 | MARK2 (transcript variant 2) |
||||
| Recombinant protein of human MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760915 | MARK2 (full length, N-term HIS tag, transcript variant 1) |
||||
| Purified recombinant protein of Human MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 1, full length, with N-terminal HIS tag, expressed in E. coli, 50ug | |||||
![]() |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY417631 | MARK2 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC229374L2V | Lenti ORF particles, MARK2 (mGFP-tagged)-Human MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 4, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,762.00
|
|
| OriGene Technologies, Inc. | ||
| RC229374L1V | Lenti ORF particles, MARK2 (Myc-DDK-tagged)-Human MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 4, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,587.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR210289L2V | Lenti ORF particles, Mark2 (GFP-tagged) - Mouse MAP/microtubule affinity-regulating kinase 2 (Mark2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,500.00
|
|
| OriGene Technologies, Inc. | ||
| MR210289L1V | Lenti ORF particles, Mark2 (Myc-DDK-tagged) - Mouse MAP/microtubule affinity-regulating kinase 2 (Mark2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,350.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR208831L2V | Lenti ORF particles, Mark2 (GFP-tagged ORF) - Rat MAP/microtubule affinity-regulating kinase 2 (Mark2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,500.00
|
|
| OriGene Technologies, Inc. | ||
| RR208831L1V | Lenti ORF particles, Mark2 (Myc-DDK-tagged ORF) - Rat MAP/microtubule affinity-regulating kinase 2 (Mark2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,350.00
|
|
| OriGene Technologies, Inc. | ||











+1 additional image

